Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/EGETIS-THERAPEUTICS-AB-61747360/news/Egetis-Therapeutics-AB-Announces-Site-Activation-in-the-Pivotal-Retriact-Trial-for-Emcitate-44255270/?utm_source=whatsapp&utm_medium=social&utm_campaign=share